Kaya, AdnanKeskin, MuhammedGüvenç, Tolga SinanTatlısu, Mustafa AdemKayapınar, Osman2020-04-302020-04-3020190001-53851784-973Xhttps://doi.org/10.1080/00015385.2018.1439704https://hdl.handle.net/20.500.12684/5092Guvenc, Tolga Sinan/0000-0002-6738-266X; Keskin, Muhammed/0000-0002-4938-0097WOS: 000459619200005PubMed: 29475415Background: The prognostic value of thrombolysis in myocardial infarction (TIMI) risk index (TRI) has been reported in patients with coronary artery disease. In this study, we evaluated the additional prognostic value of blood urea nitrogen (BUN) level to the TRI in patients with ST-segment elevation myocardial infarction (STEMI). Methods: We evaluated the in-hospital and long-term (3-year) prognostic value of modified TRI (mTRI) in patients with STEMI. The mTRI is calculated using the following equation; mTRI = (TRI x BUN)/10. Patients were stratified into 5 groups according to 20-point increments of mTRI. Results: The patients with higher mTRI had significantly higher in-hospital and long-term mortality. The risk for in-hospital and long-term mortality was highest for those within the Q5 (36.8 and 42.3%, respectively) and it was significantly higher than all the other groups (p < .001 for both). Conclusions: In this study, the prognostic value of TRI has been augmented by multiplication of TRI with BUN/10. Therefore, we present a pilot study of association of mTRI with overall STEMI patients.en10.1080/00015385.2018.1439704info:eu-repo/semantics/closedAccessST-elevation myocardial infarctionprimary percutaneous interventionmortalityrisk assessmentArticle7412936WOS:000459619200005Q3Q4